Wholly-Owned Subsidiary, Mernova Medicinal Inc. Continues Strong Progress In Q2 Securing C$593,926 In New Purchase Orders During May
Creso Pharma Secures Firm Commitments To Raise $2.5M, Extends Secured Notes And Streamlines Balance Sheet With Debt To Equity Conversions
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
